{"id":{"repo_id":"msu","oai_identifier":"oai:d.lib.msu.edu:dnp_42"},"canonical_url":"https://search.dev.ndltd.org/etd/msu/oai:d.lib.msu.edu:dnp_42","repository":{"repo_id":"msu","name":"Michigan State University","base_url":"https://d.lib.msu.edu/oai"},"display":{"title":"Identifying a minimal sugammadex dosing strategy","abstract":"This quality improvement project looks at Sugammadex dosing regimens in a facility that uses qualitative assessment to assess neuromuscular recovery. To determine how dosing of Sugammadex impacts residual paralysis three dosing groups will be compared, the facility standard dosing regime of 200 mg, the manufacture recommended 2mg/kg and what recent literature recommends 1mg/kg. To determine residual paralysis tidal volume and negative inspiratory flow will be measured. This quality improvement project has the potential to reduce incidences of residual paralysis in facilities using qualitative assessment.","abstract_html":"This quality improvement project looks at Sugammadex dosing regimens in a facility that uses qualitative assessment to assess neuromuscular recovery. To determine how dosing of Sugammadex impacts residual paralysis three dosing groups will be compared, the facility standard dosing regime of 200 mg, the manufacture recommended 2mg/kg and what recent literature recommends 1mg/kg. To determine residual paralysis tidal volume and negative inspiratory flow will be measured. This quality improvement project has the potential to reduce incidences of residual paralysis in facilities using qualitative assessment.","abstract_has_math":false,"creators":["Cantu, Ashlea C. (Ashlea Catherine)","Caron, Eric A.","Laginess, Michelle L. (Michelle Lynn)"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":["Lourens, Gayle"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2022,"date_issued":"2022","date_published":"2022","updated_at":"2026-07-24T03:16:39Z","subjects":["Sugammadex","Paralysis","Surgery"],"languages":["English"],"rights":["In Copyright"],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["dnp:42","oclc:1378907438","local:R_e5v1Jmgt34Psb17"],"render_values":[{"text":"dnp:42","href":null,"code":true},{"text":"oclc:1378907438","href":null,"code":true},{"text":"local:R_e5v1Jmgt34Psb17","href":null,"code":true}]}]},"links":{"outbound_url":"https://doi.org/doi:10.25335/t1t3-g976","outbound_label":"DOI","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Lourens, Gayle"]},{"key":"dc:creator","label":"Author","values":["Cantu, Ashlea C. (Ashlea Catherine)","Caron, Eric A.","Laginess, Michelle L. (Michelle Lynn)"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2022"]},{"key":"dc:relation","label":"Dc Relation","values":["Doctor of Nursing Practice Projects"]},{"key":"dc:type","label":"Dc Type","values":["Text","Theses","Posters"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Sugammadex","Paralysis","Surgery"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["English"]},{"key":"dc:rights","label":"Dc Rights","values":["In Copyright"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["dnp:42","oclc:1378907438","local:R_e5v1Jmgt34Psb17","https://doi.org/doi:10.25335/t1t3-g976"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["This quality improvement project looks at Sugammadex dosing regimens in a facility that uses qualitative assessment to assess neuromuscular recovery. To determine how dosing of Sugammadex impacts residual paralysis three dosing groups will be compared, the facility standard dosing regime of 200 mg, the manufacture recommended 2mg/kg and what recent literature recommends 1mg/kg. To determine residual paralysis tidal volume and negative inspiratory flow will be measured. This quality improvement project has the potential to reduce incidences of residual paralysis in facilities using qualitative assessment.","Thesis (D.N.P.)--Michigan State University. Nurse anesthesiology, 2022","Includes bibliographical references"]},{"key":"dc:format","label":"Dc Format","values":["1 unnumbered page","application/pdf"]},{"key":"dc:title","label":"Title","values":["Identifying a minimal sugammadex dosing strategy"]}]}],"canonical_facts":{"dc:contributor":["Lourens, Gayle"],"dc:creator":["Cantu, Ashlea C. (Ashlea Catherine)","Caron, Eric A.","Laginess, Michelle L. (Michelle Lynn)"],"dc:date":["2022"],"dc:description":["This quality improvement project looks at Sugammadex dosing regimens in a facility that uses qualitative assessment to assess neuromuscular recovery. To determine how dosing of Sugammadex impacts residual paralysis three dosing groups will be compared, the facility standard dosing regime of 200 mg, the manufacture recommended 2mg/kg and what recent literature recommends 1mg/kg. To determine residual paralysis tidal volume and negative inspiratory flow will be measured. This quality improvement project has the potential to reduce incidences of residual paralysis in facilities using qualitative assessment.","Thesis (D.N.P.)--Michigan State University. Nurse anesthesiology, 2022","Includes bibliographical references"],"dc:format":["1 unnumbered page","application/pdf"],"dc:identifier":["dnp:42","oclc:1378907438","local:R_e5v1Jmgt34Psb17","https://doi.org/doi:10.25335/t1t3-g976"],"dc:language":["English"],"dc:relation":["Doctor of Nursing Practice Projects"],"dc:rights":["In Copyright"],"dc:subject":["Sugammadex","Paralysis","Surgery"],"dc:title":["Identifying a minimal sugammadex dosing strategy"],"dc:type":["Text","Theses","Posters"]},"updated_at":"2026-07-24T03:16:39Z"}